Growth arrest by the LKB1 tumor suppressor: Induction of p21WAF1/CIP1

Human Molecular Genetics

Volumn 11, Issue 13, 2002, Pages 1497-1504

  Tiainen, Marianne ^a   Vaahtomeri, Kari ^a   Ylikorkala, Antti ^a   Mäkelä, Tomi P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; CYTOPLASM PROTEIN; NUCLEAR PROTEIN; PROTEIN P21; PROTEIN P53; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CELL CYCLE G1 PHASE; CONTROLLED STUDY; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; GERM LINE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOLECULAR GENETICS; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; COS CELLS; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; MUTATION; PHOSPHOTRANSFERASES; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

ANIMALIA;

EID: 0037096833     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.13.1497     Document Type: Article

References (33)

1. Very high risk of cancer in familial Peutz-Jeghers syndrome
2. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity
3. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer
4. Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome
5. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome
6. The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase
7. Cloning and characterization of a novel serine/threonine protein kinase expressed in early Xenopus embryos
8. The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry
9. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice
10. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth
11. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest
12. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest
13. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death
14. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1
15. Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients
16. CRM1 is an export receptor for leucine-rich nuclear export signals
17. Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1
18. 1-phase progression
19. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
20. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
21. 1 arrest
22. Analysis of wild-type and mutant p21WAF-1 gene activities
23. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
24. WAF1, a potential mediator of p53 tumor suppression
25. Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding
26. Human melanoma cell line UV responses show independency of p53 function
27. Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome
28. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues
29. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
30. Direct control of the Forkhead transcription factor AFX by protein kinase B
31. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry
32. Physical and functional interaction between p53 mutants and different isoforms of p73